Home
English
English
简体中文
Sign In
Help Desk
Journals
Advanced Search
BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Featured Articles
Journals
Submit a Manuscript
Articles Published Processes
Keyword:
Schizophrenia
Page 1 of 2 ( 85 items )
<<
1
2
>>
1
Neural correlates of aggression in schizophrenia: An event-related potential study using the competitive reaction time task
8/8/2025 10:23:17 AM |
Browse: 15 |
Download: 77
2
Cell-free DNA in extracellular vesicles: A candidate biomarker of schizophrenia
8/8/2025 10:23:11 AM |
Browse: 13 |
Download: 49
3
Interaction between the brain and multiple organ systems in schizophrenia
8/8/2025 10:23:10 AM |
Browse: 14 |
Download: 54
4
Gut-brain connection in schizophrenia: A narrative review
4/30/2025 8:58:20 AM |
Browse: 57 |
Download: 184
5
Effectiveness and safety of blonanserin monotherapy in first-episode schizophrenia with and without prominent negative symptoms: A prospective study
4/30/2025 8:58:18 AM |
Browse: 54 |
Download: 264
6
Therapeutic efficacy of transcranial direct current stimulation in treating auditory hallucinations in schizophrenia: A meta-analysis
2/26/2025 4:37:22 AM |
Browse: 55 |
Download: 335
7
Repetitive transcranial magnetic stimulation guided by event-related potential P300 application in schizophrenia
2/26/2025 4:37:20 AM |
Browse: 58 |
Download: 406
8
Metabolic pathway modulation by olanzapine: Multitarget approach for treating violent aggression in patients with schizophrenia
12/18/2024 8:36:43 AM |
Browse: 77 |
Download: 541
9
Brain-derived neurotrophic factor alterations and cognitive decline in schizophrenia: Implications for early intervention
12/18/2024 8:36:42 AM |
Browse: 77 |
Download: 362
10
Who can benefit more from its twelve-week treatment: A prospective cohort study of blonanserin for patients with schizophrenia
11/7/2024 8:33:31 AM |
Browse: 94 |
Download: 564
11
Advancement in utilization of magnetic resonance imaging and biomarkers in the understanding of schizophrenia
11/7/2024 5:10:58 AM |
Browse: 99 |
Download: 327
12
Expression level of myocardial enzymes in patients with schizophrenia: Predictive value in the occurrence of violence
9/11/2024 7:02:38 AM |
Browse: 109 |
Download: 532
13
Identification of male schizophrenia patients using brain morphology based on machine learning algorithms
6/19/2024 12:40:27 PM |
Browse: 153 |
Download: 837
14
Correlation between cognitive impairment and metabolic imbalance of gut microbiota in patients with schizophrenia
10/12/2023 4:44:25 AM |
Browse: 250 |
Download: 874
15
Effect of cognitive behavioral group therapy on rehabilitation of community patients with schizophrenia: A short-term randomized control trial
8/17/2023 7:08:15 AM |
Browse: 236 |
Download: 935
16
Gastrointestinal and liver disease in patients with schizophrenia: A narrative review
10/12/2022 4:24:12 AM |
Browse: 445 |
Download: 1115
17
Delayed improvements in visual memory task performance among chronic schizophrenia patients after high-frequency repetitive transcranial magnetic stimulation
9/20/2022 11:01:13 AM |
Browse: 410 |
Download: 1339
18
Galectin-3 mediated risk of inflammation in stable schizophrenia, with only possible secondary consequences for cognition
9/20/2022 11:01:13 AM |
Browse: 415 |
Download: 1323
19
ABCB9 polymorphism (rs61955196) is associated with schizophrenia in Chinese Han population
7/19/2022 7:32:06 AM |
Browse: 450 |
Download: 1348
20
Social media and schizophrenia: An update on clinical applications
7/19/2022 7:32:06 AM |
Browse: 418 |
Download: 1022
21
Successful treatment of hyperglycemia with liraglutide in a hospitalized 27-year-old patient with schizophrenia: A case report
7/11/2022 8:36:01 AM |
Browse: 438 |
Download: 1107
22
Disrupted leptin-fatty acid biosynthesis is an early manifestation of metabolic abnormalities in schizophrenia
6/14/2022 7:57:01 AM |
Browse: 558 |
Download: 1085
23
Differences between delusional disorder and schizophrenia: A mini narrative review
5/18/2022 6:40:21 AM |
Browse: 529 |
Download: 983
24
Abnormal synaptic plasticity and impaired cognition in schizophrenia
4/13/2022 7:47:57 AM |
Browse: 467 |
Download: 1253
25
Adult neural stem cells and schizophrenia
3/25/2022 7:41:02 AM |
Browse: 430 |
Download: 1158
26
Trajectories of response in schizophrenia-spectrum disorders: A one-year prospective cohort study of antipsychotic effectiveness
3/18/2022 12:26:44 PM |
Browse: 514 |
Download: 1503
27
Therapeutic use of melatonin in schizophrenia-more than meets the eye!
3/18/2022 12:26:44 PM |
Browse: 526 |
Download: 1369
28
Insights into myelin dysfunction in schizophrenia and bipolar disorder
2/17/2022 8:22:35 AM |
Browse: 486 |
Download: 1232
29
Prevalence and clinical characteristics of COVID-19 in inpatients with schizophrenia in Wuhan, China
1/18/2022 2:50:51 AM |
Browse: 591 |
Download: 1527
30
Psychological impact of the COVID-19 pandemic on individuals with serious mental disorders: A systematic review of the literature
12/15/2021 9:38:23 AM |
Browse: 509 |
Download: 1306
31
Differential aberrant connectivity of precuneus and anterior insula may underpin the diagnosis of schizophrenia and mood disorders
12/15/2021 9:38:23 AM |
Browse: 569 |
Download: 1380
32
Newer antipsychotics: Brexpiprazole, cariprazine, and lumateperone: A pledge or another unkept promise?
12/15/2021 9:38:23 AM |
Browse: 475 |
Download: 1033
33
Polyamines and polyamine-metabolizing enzymes in schizophrenia: Current knowledge and concepts of therapy
12/15/2021 9:38:23 AM |
Browse: 556 |
Download: 1242
34
Breast cancer in schizophrenia could be interleukin-33-mediated
11/17/2021 2:18:21 AM |
Browse: 535 |
Download: 1235
35
Therapeutic role of yoga on neuropsychological disorders
10/15/2021 9:56:18 AM |
Browse: 612 |
Download: 1534
36
Metabolic disturbances associated with antipsychotic drug treatment in patients with schizophrenia: State-of-the-art and future perspectives
10/15/2021 9:56:18 AM |
Browse: 602 |
Download: 1315
37
Galectin-3 possible involvement in antipsychotic-induced metabolic changes of schizophrenia: A minireview
10/13/2021 8:37:10 AM |
Browse: 550 |
Download: 1293
38
Therapeutic use of melatonin in schizophrenia: A systematic review
8/12/2021 8:46:10 AM |
Browse: 708 |
Download: 1507
39
Clozapine resistant schizophrenia: Newer avenues of management
8/12/2021 8:46:10 AM |
Browse: 576 |
Download: 1167
40
Novel approaches in schizophrenia-from risk factors and hypotheses to novel drug targets
7/15/2021 10:19:10 AM |
Browse: 844 |
Download: 1588
41
Implications from translational cross-validation of clinical assessment tools for diagnosis and treatment in psychiatry
5/13/2021 8:59:52 AM |
Browse: 598 |
Download: 1268
42
What gets in the way of social engagement in schizophrenia?
1/11/2021 11:00:37 AM |
Browse: 589 |
Download: 1634
43
How to construct neuroscience-informed psychiatric classification? Towards nomothetic networks psychiatry
1/11/2021 11:00:37 AM |
Browse: 718 |
Download: 1411
44
Dietary modification in the treatment of schizophrenia spectrum disorders: A systematic review
8/13/2020 5:58:52 AM |
Browse: 951 |
Download: 1675
45
Suicide attempt using potassium tablets for congenital chloride diarrhea: A case report
4/24/2020 10:13:26 AM |
Browse: 833 |
Download: 1491
46
Prevalence and associated factors of suicide among hospitalized schizophrenic patients
2/26/2020 3:48:21 PM |
Browse: 905 |
Download: 2152
47
Do adjunctive art therapies reduce symptomatology in schizophrenia? A meta-analysis
12/10/2019 10:00:07 AM |
Browse: 1286 |
Download: 1878
48
Women who suffer from schizophrenia: Critical issues
11/9/2018 9:22:52 AM |
Browse: 1258 |
Download: 1632
49
Glutamate transporters, EAAT1 and EAAT2, are potentially important in the pathophysiology and treatment of schizophrenia and affective disorders
6/28/2018 10:44:41 AM |
Browse: 1149 |
Download: 1599
50
Promoting recovery from severe mental illness: Implications from research on metacognition and metacognitive reflection and insight therapy
3/21/2018 3:05:53 AM |
Browse: 1227 |
Download: 1705
Page 1 of 2 ( 85 items )
<<
1
2
>>
Write to the Help Desk
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345